Big Pharma should go back to basics, says Novartis CEO

01/3/2013 | Wall Street Journal, The

Pharmaceutical companies shouldn't expect value creation simply by finding new ways to market existing drugs, says Novartis CEO Joseph Jimenez. Long-term growth can only come from a continuous stream of new treatments, he argues. "The industry needs to spend more money on R&D and less on sales and marketing," he says.

View Full Article in:

Wall Street Journal, The

Published in Briefs:

SmartBrief Job Listings for Business

Job Title Company Location
Manager, Technical Staffing
U.S. Cellular
Chicago, IL
Human Resource Director
Confidential
Salt Lake City, UT
Administrative Management Specialist
Smithsonian Institute
Washington, DC
Manager, Human Resources
L'OREAL USA
Florence, KY
Generalist - Human Resources
Marriott Hotels Resorts
Brooklyn, NY